Introduction {#s1}
============

The intestinal epithelium is a highly organized and rapidly self-renewing tissue with a proliferative crypt compartment and a differentiated villus compartment. The constant cellular turnover of the intestinal epithelium is maintained by stem cells, which reside at the bottom of the crypt and generate rapidly dividing daughter cells, the transit amplifying (TA) cells. The TA cells differentiate into various intestinal epithelial cell (IEC) types, such as Paneth cells, goblet cells, enteroendocrine cells, Tuft cells, M cells and the most prominent type, the absorptive enterocytes ([@DMM031088C20]).

Forming a continuous single-layered sheet, IECs separate the external environment from the internal one. The establishment of epithelial cell polarity with distinct apical and basolateral plasma membrane domains (described in detail below) is pivotal for barrier formation and for the uptake and vectorial transport (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) of nutrients. The apical membrane of IECs faces the intestinal lumen, whereas the basolateral membrane borders neighboring cells and the underlying basement membrane, which covers the lamina propria (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}). Both membrane domains are composed of distinct proteins and lipids, which fulfill their distinct functions. These proteins and lipids are sorted and transported to the correct membrane domain via different intracellular routes, with cytoskeletal organization playing an important role in mediating this transport ([@DMM031088C6]; [@DMM031088C67]).

###### Box 1. Glossary

**Adherens junctions:** or zona adherens; part of the junctional complex located in the lateral domain, consisting mostly of E-cadherin and mediating the strength of cell-cell adhesion.

**Apical recycling endosome (ARE):** a vesicle that contains apical membrane-destined cargo and RAB11A.

**Brush border:** densely packed microvilli on the apical side of enteroctyes.

**Caco-2 cells:** a cell line of heterogeneous human epithelial colorectal adenocarcinoma cells.

**Caco-2~BBE~:** a subclone of Caco-2 cells that uniformly expresses a highly ordered brush border (BB) cytoskeleton.

**Common recycling endosome (CRE):** a vesicle that contains apical or basolateral membrane-destined cargo and RAB11A.

**Desmosomal junctions:** part of the junctional complex, contains cadherin family members.

**Enteropathy:** any pathology of the intestine.

**Hemidesmosomes:** located at the basal part of the basolateral membrane, consist of dystroglycans and integrin receptors, facilitate the attachment to the basement membrane.

**Hypogammaglobulinemia:** a type of primary immunodeficiency resulting in severe reduction of gamma globulins in the blood due to a lack of antibody production.

**Junctional complex:** located in the lateral membrane just below the apical membrane, consists of tight, adherens and desmosomal junctions.

**Lamina propria:** connective tissue underlying the epithelium.

**Macropinocytosis:** a nonspecific cellular process to take in extracellular fluids by invagination of the plasma membrane.

**Microvilli:** extrusions from the apical membrane, supported by an actin filament network, to increase the absorptive surface area of cells.

**Microvillus inclusions:** intracellular vesicle-like structures that are internally (luminally) lined by microvilli, characteristic of microvillus inclusion disease.

**Paracellular transport:** the transfer of substances across an epithelium by passing through the intercellular space between the cells, controlled by junction complexes.

**Terminal web:** a filamentous structure composed primarily of actin filaments at the apical surface of epithelial cells that possess microvilli.

**Tight junctions:** or zona occludens; part of the junctional complex, located between the apical domain and the lateral surface domain, contains proteins of the claudin family and controls the paracellular transport of electrolytes and water.

**Total parenteral nutrition (TPN):** intravenous feeding that provides patients with all the fluid and the essential nutrients they need when feeding by mouth is inhibited.

**Vectorial transport:** transport of an ion or molecule across an epithelium in only one direction.

The mislocalization of epithelial proteins can disrupt the polarity and function of the epithelium and have far-reaching consequences for the health of cells and organisms. For example, the mislocalization of apical proteins in IECs leads to malnutrition, owing to the failure to properly absorb nutrients across the apical membrane, and to potentially fatal diarrheal disorders ([@DMM031088C81]). By contrast, the mislocalization of basolateral proteins correlates with loss of epithelial architecture, cancer development ([@DMM031088C32]), and with inflammatory bowel disease ([@DMM031088C53]).

In this Review, we focus on the structural regulation of polarity and intracellular transport mechanisms in IECs, the importance of which is illustrated by the pathophysiological defects in microvillus inclusion disease (MVID). MVID is a severe neonatal enteropathy (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) that manifests mostly during the first days of life. It was first described in 1978 as a familial enteropathy characterized by protracted diarrhea from birth and failure to thrive ([@DMM031088C26]). Current treatment consists of life-long total parenteral nutrition (TPN; see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) and eventual small bowel and/or liver transplantation ([@DMM031088C98]). The pathological hallmarks of MVID are increased numbers of subapical vesicles, variable loss of microvilli (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) and the presence of microvillus inclusions (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) in villus enterocytes ([@DMM031088C111]) ([Box 2](#DMM031088B2){ref-type="boxed-text"}). MVID is caused by heterogenous mutations in myosin Vb (*MYO5B*) ([@DMM031088C79]; [@DMM031088C129]) or syntaxin 3 (*STX3*) genes ([@DMM031088C138]), which both encode proteins that function in the intracellular trafficking and membrane fusion cell machinery. Mutations in syntaxin binding protein 2 (*STXBP2*) also result in a MVID phenotype in the intestine ([@DMM031088C118]; [@DMM031088C134]) ([Table 1](#DMM031088TB1){ref-type="table"}).

###### Box 2. Pathophysiology of microvillus inclusion disease

The gold standard of MVID diagnosis is the morphological analysis of biopsies obtained from the small intestine of patients. On examination, MVID biopsies show villus atrophy with little crypt hyperplasia and the absence of strong inflammatory infiltrate in the lamina propria ([@DMM031088C111]). It has to be kept in mind that phenotypic changes can be intermingled with normal appearing epithelium.

**Histological characteristics of MVID**

• Absent or abnormal microvilli, which can be aberrant in form or reduced in number, in combination with discontinuity of the brush border and shortened, disoriented microvillus core rootlets

• Subapical staining for alkaline phosphatase (AP) ([@DMM031088C62])

• Periodic acid-Schiff (PAS) staining of apically located intracellular granules ([@DMM031088C49])

• Subapical staining for CD10 ([@DMM031088C56])

• Diffuse apical cytoplasmic staining for RAB11A in enterocytes ([@DMM031088C122]; [@DMM031088C124])

**Ultrastructural characteristics by electron microscopy ([@DMM031088C49])**

• Subapical microvillus inclusions at the tip of the villi

• Diffuse microvillus atrophy and dystrophy

• Lateral membrane microvilli that project into the intercellular cleft

• Rod-like immature microvilli that reside intracellularly beneath the terminal web

• Abnormal vesicle-like organelles of various sizes, shapes and electron density, preferably within areas of microvilli-denuded apical surfaces

• Cytoplasmic inclusions lined by inward-pointing microvilli palisades, which feature irregular or rudimentary microvilli, and contain debris or amorphous components

• Lysosomes with heterogeneous contents. The number of lysosomes present correlates with the degree of membrane damage, suggesting they originate from autophagocytosis

**Extra-intestinal ultrastructural characterization**

Besides the intestine, microvillus inclusions can be identified in epithelial cells that line the stomach, gallbladder ([@DMM031088C93]) and renal tubules ([@DMM031088C23]).

###### 

**Characteristic features of human MVID caused by mutations in MYO5B, STX3 or STXBP2**

![](dmm-11-031088-i1)

The pathophysiological mechanism of MVID is currently not fully understood. Here, we review the recent developments in studying the pathophysiology of MVID using various approaches, including genetically manipulated cell lines and mouse models. We also propose a novel model to explain the pathological hallmarks of this disease, and discuss how recent insights from experimental models support it.

Intestinal epithelial cell polarity {#s2}
===================================

The intestine is lined by a simple columnar epithelium of polarized cells. The apical and basolateral membranes of all IECs are two biochemically and functionally distinct domains that each contain different protein and lipid compositions, which mediate their specialized functions. In this Review, we will specifically focus on enterocytes, the absorptive cells in the intestine, because the apical surface area of enterocytes is extended considerably by the formation of microvilli. The microvilli form a brush border (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}), which contains various apical proteins necessary for nutrient absorption and digestion. The establishment and maintenance of these distinct apical and basolateral membrane domains requires a highly specialized subcellular machinery, which traffics and recycles proteins to their appropriate location.

MYO5B and STX3 are both important mediators of the trafficking and membrane fusion machinery that maintains epithelial polarity, and defects in either of these proteins can cause MVID. As such, we use MVID as a model system to discuss the properties of the apical and basolateral membranes, and to examine how vectorial transport, membrane recycling and membrane fusion are regulated to maintain epithelial polarity.

The apical membrane {#s2a}
-------------------

The apical plasma membrane of IECs faces the intestinal lumen and has two main functions: the formation of a defensive barrier against pathogens, and the processing and uptake of nutrients. It consists of two layers, the inner one being rich in phosphatidylinositol-4,5-bisphosphate, and the outer one containing glycosphingolipids and cholesterol. The outer layer is able to form microdomains, also known as lipid rafts ([@DMM031088C25]). Proteins that have to be transported to the apical plasma membrane are modified post-translationally to feature apical sorting signals, such as *N*- and *O*-linked glycans and glycosylphosphatidylinositol anchors, and are then sorted and packaged into distinct transport carriers that leave the *trans-*Golgi network (TGN) ([@DMM031088C95]). The way in which proteins are modified determines the route they take to the apical membrane; for example, via the lipid raft-dependent or -independent trafficking route ([@DMM031088C50]). Mutations interfering with *O*-linked glycosylation of the sucrase-isomaltase (SI) enzyme are believed to be associated with aberrant sorting of SI to the basolateral membrane in congenital sucrase-isomaltase deficiency (CSID) (Keiser et al., 2006).

As mentioned above, the microvilli extrude from the apical membrane of intestinal enterocytes. Each mature enterocyte contains ∼1000 microvilli, which are densely packed and together form the brush border ([@DMM031088C77]). The brush border significantly increases the apical surface area, thereby facilitating efficient nutrient absorption and host defense against the luminal microbiota ([@DMM031088C66]; [@DMM031088C78]; [@DMM031088C112]).

The core of each microvillus consists of bundles of actin filaments that are interconnected by various proteins, including villin, plastin (fimbrin), espin and epidermal growth factor receptor kinase substrate 8 (ESP8) ([@DMM031088C21]; [@DMM031088C46]; [@DMM031088C92]). The microvilli are anchored to the subapical terminal web (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) by myosin II ([@DMM031088C46]). Strikingly, several cytoskeletal genes, including those encoding villin, plastin and actin, are temporarily upregulated during enterocyte differentiation ([@DMM031088C18]), and mouse models lacking myosin IA, myosin VI, ESP8, ezrin, espin, villin and/or plastin display defects in brush border formation ([@DMM031088C17]; [@DMM031088C35]; [@DMM031088C43]; [@DMM031088C45]; [@DMM031088C92]; [@DMM031088C102]; [@DMM031088C125]; [@DMM031088C127]). The adhesion of the apical plasma membrane to the actin bundles in the core of the microvilli is established by myosin IA ([@DMM031088C69]), myosin VI ([@DMM031088C45]), and by members of the ezrin-radixin-moesin (ERM) family ([@DMM031088C33]).

In IECs, activated (phosphorylated) ezrin connects the plasma membrane to the actin bundles inside the microvilli ([@DMM031088C11], [@DMM031088C10]; [@DMM031088C115]). Several kinases have been implicated in the direct phosphorylation of ezrin at T567 in IECs, including protein kinase B2/Akt2, atypical protein kinase C-iota (aPKCι) ([@DMM031088C135]), mammalian Sterile 20 (Ste20)-like kinase-4 (MST4; STK26) ([@DMM031088C41]; [@DMM031088C123]), lymphocyte-oriented kinase and Ste20-like kinase ([@DMM031088C131]), all of which have been shown to be important for microvillus formation at the apical membrane. The polarity of the apical membrane of IECs also relies on the association with the CDC42/PAR complex, which is composed of the PAR6B (PARD6B), aPKCι, PAR3 (PARD3) and CDC42 proteins. The apical localization of the CDC42/PAR complex and the ezrin kinases was shown to be dependent on RAB11A and MYO5B ([@DMM031088C30]; Michaux et al., 2016). In concordance, it was found that the polarity determinants CDC42, PAR6B and aPKCι, and the structural proteins ezrin and phospho-ezrin, were lost from the apical membrane and accumulated either in the cytoplasm or on the basal side of enterocytes in MVID patients, which suggests an inversion of cell polarity (Michaux et al., 2016).

The basolateral membrane {#s2b}
------------------------

The basolateral plasma membrane of IECs is rich in phosphatidylinositol-3,4,5-trisphosphate and is crucial for interactions between adjacent cells and with the basement membrane. Proteins that have to be transported to the basolateral membrane feature basolateral sorting signals, which are distinct from the apical sorting signals and mostly consist of simple peptide motifs located in the cytoplasmic domain of a protein ([@DMM031088C137]).

The lateral part of the basolateral membrane contains junctional complexes that tightly adhere adjacent cells to each other and control the paracellular transport (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) in epithelia ([@DMM031088C64]). The junctional complexes (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) consist of three components -- tight junctions, adherens junctions and the desmosomal junctions ([@DMM031088C31]; [@DMM031088C39]; [@DMM031088C110]) -- whereas the basal part of the basolateral membrane contains hemidesmosomes ([@DMM031088C120]).

Although it is not yet clear whether basolateral membranes are affected in MVID, the mislocalization of basolateral proteins, such as transferrin receptor and α2-integrin to the cytoplasm has been reported in some MVID patients and mouse models ([@DMM031088C106]; [@DMM031088C124]). In addition, microvilli have been found to be mislocalized to the basolateral membrane, particularly in patients with MVID caused by *STX3* mutations ([@DMM031088C138]), and in two MVID mouse models, the enterocyte-specific *Rab8a*; *Rab11a* double, and the *Rab11a* single, knockout mice ([@DMM031088C34]). These and other MVID mouse models are discussed later in this Review.

Vectorial transport and membrane recycling {#s2c}
------------------------------------------

During vectorial transport, cargo must pass through multiple compartments on its way towards the cell surface. These events are regulated by Rab proteins (44 subfamilies in humans), which modulate cargo selection and the tethering and fusion of vesicles with their target membranes ([@DMM031088C6]). The establishment and maintenance of these distinct apical and basolateral membrane domains requires a highly specialized subcellular machinery that ensures that proteins are transported and recycled to their appropriate location. Apical proteins use a direct (biosynthetic) or indirect (transcytotic) route to reach their target membrane, whereas basolateral proteins use only the direct pathway ([@DMM031088C65]; [@DMM031088C68]). Additionally, proteins from both plasma membrane domains can be endocytosed and transported back to their respective membranes via the recycling pathway ([@DMM031088C42]; [@DMM031088C128]) ([Fig. 1](#DMM031088F1){ref-type="fig"}A). Fig. 1.**Schematic overview of the intestinal trafficking machinery.** Schematics of polarized mouse enterocytes showing their cell features, cytoskeletal organization and trafficking routes. The apical surface is uppermost. (A) Apically and basolaterally destined proteins follow different pathways (denoted by arrows) to reach their target membrane. The biosynthetic route (route 1) is indicated in black line, the transcytotic route (route 2) in dashed line, and the recycling pathway (route 3) in dotted line. (B) Vesicle transport is mediated by the cytoskeleton. Long-distance transport occurs along microtubules, and is mediated by kinesin and dynein motor proteins. Short-distance transport occurs along actin filaments of the terminal web and is mediated by motor proteins of the myosin family.

In the direct (biosynthetic) route ([Fig. 1](#DMM031088F1){ref-type="fig"}A, pathway 1), proteins that are synthesized in the endoplasmic reticulum (ER) are transferred via the Golgi complex to the *trans*-Golgi network. Here, proteins are sorted into distinct apical and basolateral endosomal carrier vesicles and are then transported to either the apical or the basolateral plasma membrane ([@DMM031088C67]). Apically targeted proteins passage through the common recycling endosome (CRE; see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) or through the apical recycling endosome (ARE; see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}). Basolateral targeted proteins traffic through the CRE before reaching the basolateral plasma membrane ([@DMM031088C65]; [@DMM031088C68]).

In the indirect (transcytotic) pathway ([Fig. 1](#DMM031088F1){ref-type="fig"}A, pathway 2), newly synthesized apically destined proteins are delivered first to the basolateral plasma membrane. After a variable time on the basolateral membrane, they are endocytosed and delivered to their apical target membrane by transcytosis. Again, this could happen by passaging though endosomal compartments such as the CRE and ARE ([@DMM031088C68]).

In the recycling pathway ([Fig. 1](#DMM031088F1){ref-type="fig"}A, pathway 3), membrane proteins are endocytosed into apical early endosomes or into basolateral early endosomes ([@DMM031088C37]). Subsequently, three different fates are possible. First, the proteins can be targeted for degradation, whereby the endosomal cargo is transferred to lysosomes, which fuse to form late endosomes ([@DMM031088C5]). Second, endocytosed proteins can be rapidly recycled back to their respective membranes, which generally happens via RAB4-positive endosomal compartments ([@DMM031088C90]; [@DMM031088C117]). Third, endocytosed proteins can undergo slow recycling back to their respective membranes. In this route, apical and basolateral endocytosed cargo is first redirected to the CRE, where it is sorted again. Proteins are then directed to distinct apical and basolateral trafficking pathways, and apical proteins can passage through the ARE, which acts as an intermediate compartment ([@DMM031088C42]; [@DMM031088C90]).

Experimental findings have identified several proteins that are associated with apical endosomal trafficking and their roles in IEC polarity. Myosin Vb (MYO5B), a motor protein crucial for endosomal transport along the cytoskeleton (discussed further below), binds to both RAB11A and RAB8A in a yeast two-hybrid screen, and colocalizes with these RAB proteins in polarized MDCK and HeLa cells ([@DMM031088C44]; [@DMM031088C63]; [@DMM031088C96]). In *in vitro* studies using polarized IECs, MYO5B, RAB11A and RAB8A have been reported to associate with AREs, where they control the activity of CDC42 ([@DMM031088C14]). However, in enterocytes from MVID patients and in MYO5B-mutated Caco-2 cells (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}), RAB11A-positive AREs are mislocalized ([@DMM031088C30]; [@DMM031088C121]). Additional studies have used MYO5B mutant proteins that are unable to bind to either RAB8A or RAB11A, which result in distinct microvillus structural defects ([@DMM031088C54]; [@DMM031088C132]), indicating that RAB11A- and RAB8A-positive AREs play a pivotal role in IEC polarity. Polarized Caco2-~BBE~ cells (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}) showed a loss of microvilli upon knockdown of MYO5B. Re-expression of a specific MYO5B mutant that cannot bind to RAB11A, rescued the loss of microvilli, although it caused the formation of microvillus inclusions. By contrast, re-expression of a RAB8A binding-deficient MYO5B mutant only partly rescued microvilli loss, and no inclusions were observed in the cells. Together, these data show that MYO5B-RAB8A binding is important for microvilli formation, and that the disruption of the MYO5B-RAB11A interaction is responsible for the formation of microvillus inclusions ([@DMM031088C54]).

Cytoskeletal organization {#s2d}
-------------------------

In all trafficking routes, the transport of the distinct apical and basolateral carrier vesicles depends on the cytoskeleton and occurs along microtubules and actin filaments ([@DMM031088C40]; [@DMM031088C95]) ([Fig. 1](#DMM031088F1){ref-type="fig"}B). Microtubules run through the cytoplasm of the cells from the apical to the basal side, and interact with actin filaments at the periphery ([@DMM031088C40]; [@DMM031088C101]). The minus ends of microtubules face the apex of the cell, and the plus ends the basal side near the Golgi complex ([@DMM031088C2]; [@DMM031088C24]). Long-distance transport along microtubules is mainly driven by two types of motor proteins: dyneins, which are minus end directed, and kinesin family proteins, which are mainly plus end directed ([@DMM031088C13]; [@DMM031088C40]; [@DMM031088C70]) ([Fig. 1](#DMM031088F1){ref-type="fig"}B). Recently, it has been shown that the organization of the apico-basal microtubules in polarized IECs is regulated by the direct binding of calmodulin-regulated spectrin-associated protein 3 (CAMSAP3) to the spectraplankin protein actin cross-linking factor 7 (ACF7) ([@DMM031088C80]; [@DMM031088C126]). Experiments in Caco-2 cells have demonstrated that CAMSAP3 strongly localizes to the apical cell membrane and tethers the minus ends of microtubules to the apical side ([@DMM031088C126]). Loss of CAMSAP3 leads to RAB11A mislocalization and to the inhibition of brush border formation, whereas loss of ACF7 affects the lumen formation in three-dimensionally cultured Caco-2 cells ([@DMM031088C80]). Additionally, the disassembly of microtubules by colchicine treatment leads to polarity defects in IECs *in vivo* and *in vitro* ([@DMM031088C1]; [@DMM031088C40]). Together, these findings confirm the importance of microtubule organization for proper IEC polarity.

The actin cytoskeleton is made up of shorter filaments that form a dense network located underneath the plasma membranes. Short-distance transport along actin filaments is mediated by myosin motor proteins ([@DMM031088C70]) ([Fig. 1](#DMM031088F1){ref-type="fig"}B). Myosin VI is the only myosin motor that moves towards the minus ends of actin filaments, which are anchored in the subapical terminal web. Myosin VI mediates clathrin-dependent endocytosis of several apical proteins and trafficking to the subapical endosome ([@DMM031088C3]; [@DMM031088C45]). Myosin V (MYO5) is present in the terminal web and at the distal ends of the microvilli ([@DMM031088C47]) and has three subclasses (MYO5A, MYO5B and MYO5C). MYO5B plays a particularly important role in the intestinal epithelium. It works as a tether, mediating the transport of endosomes toward the plus ends of actin filaments in the tip of the microvilli, and thereby has a crucial role in the establishment and maintenance of IEC polarity ([@DMM031088C52]; [@DMM031088C97]).

Membrane fusion {#s2e}
---------------

Once the AREs are in close proximity to the apical membrane; following their transport along the microtubule and actin cytoskeleton, their protein contents have to be released or incorporated into the membrane. This process involves the AREs docking to, and subsequently fusing with, the target membrane, which is mediated by soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) complexes ([@DMM031088C48]). SNARE complexes are composed of vesicle-SNAREs (v-SNAREs), which are associated with the cargo-loaded vesicle, and target-SNAREs (t-SNAREs), which are transmembrane proteins in the plasma membrane. T-SNAREs consist of syntaxins and synaptosomal-associated proteins (SNAP), whereas v-SNAREs are a family of vesicle-associated membrane proteins (VAMPs). In IECs, vesicle tethering and fusion is controlled by the v-SNAREs synaptotagmin-like protein 4a (SLP4A) and vesicle-associated membrane protein 7 (VAMP7), in conjunction with RAB27A/RAB3/RAB8A/RAB11A proteins and the t-SNARE syntaxin-3 (STX3) ([@DMM031088C12]; [@DMM031088C29]; [@DMM031088C38]; [@DMM031088C87]; [@DMM031088C94]; [@DMM031088C132]; [@DMM031088C138]). Furthermore, the Sec1-related protein syntaxin binding protein 2 (STXBP2), also known as Sec1/Munc18-like protein (MUNC18-2), mediates binding of SLP4A with STX3 at the apical plasma membrane of IECs, where it regulates the accessibility of its SNARE partners ([@DMM031088C94]; [@DMM031088C134]). It has been recently shown that the apical exocytosis route requires MYO5B, RAB11A, RAB8A, SLP4A, VAMP7, STXBP2 and STX3, which together regulate the recycling and localization of several apical membrane proteins, such as sodium-hydrogen exchanger 3 (NHE3), cystic fibrosis transmembrane conductance regulator (CFTR) and solute carrier family 2 member 5 (GLUT5) ([@DMM031088C132]). Mutations in *STX3* or *STXBP2* cause MVID and result in severe diarrhea ([@DMM031088C118]; [@DMM031088C134]; [@DMM031088C138]), indicating that, in addition to MYO5B-regulated trafficking, the membrane fusion machinery also has an important role in the maintenance of IEC polarity ([Fig. 2](#DMM031088F2){ref-type="fig"}). Fig. 2.**Model to explain MVID pathology caused by mutations in *STX3*, *STXBP2* or *MYO5B*.** The panels depict healthy control and mutant human enterocytes, showing endosomal trafficking routes. The apical surface is uppermost. (A) In healthy (control) enterocytes, vesicles containing apical proteins travel from the Golgi complex to the apical membrane. These vesicles fuse with the apical membrane through the interaction of a v-SNARE with the t-SNARE, syntaxin 3 (STX3) and its binding partner STXBP2. (B) STX3/STXBP2-deficient enterocytes fail to deliver apically destined vesicles to the apical membrane and might instead deliver apical recycling endosomes (AREs) that contain apical proteins to the basolateral membrane, leading to the formation of basolateral microvilli. In the apical membrane, microvilli are distorted or absent and are instead accumulating in microvillus inclusions, which are formed by a yet unresolved mechanism. (C) *MYO5B* mutant enterocytes also fail to deliver apically destined vesicles to the apical membrane, lack apical microvilli and are prone to form microvillus inclusions. Question marks in B and C indicate unresolved mechanisms.

Disrupted intestinal epithelial cell polarity in MVID {#s3}
=====================================================

As mentioned above, most aspects of IEC polarity are affected in MVID. Thus, we use MVID as a model to understand how IEC polarity is regulated. Currently, the pathological hallmarks of MVID are explained by three distinct models: the trafficking, the recycling and the local induction models. In addition to these, we propose a novel mechanistic model that combines elements from these three models to explain all the hallmarks of MVID. In this section, we discuss the characteristics and pathophysiology of MVID and the experimental model systems that are being used to study MVID, including genetically modified cell lines and mouse models.

Characteristics of MVID {#s3a}
-----------------------

MVID was previously known as Davidson\'s disease, congenital microvillus atrophy, and as intestinal microvillus dystrophy ([@DMM031088C22]; [@DMM031088C85]). MVID clusters in certain ethnic groups, including Arabs ([@DMM031088C85]), Iraqi Jews ([@DMM031088C119]) and the American Navajo ([@DMM031088C88]), owing to consanguinity or a small gene pool. Based on the time of onset, two distinct forms of MVID can be distinguished: early-onset MVID, which occurs within the first week of life, and late-onset MVID, which occurs within the first 3 months of life ([@DMM031088C79]; [@DMM031088C85]; [@DMM031088C89]). Affected newborns present with extremely watery diarrhea, dehydration and weight loss ([@DMM031088C93]; [@DMM031088C109]).

MVID belongs to the congenital diarrheal disorders (CDD), which are subdivided into secretory, osmotic and mixed-type diarrhea, and can be either of epithelial or of immunological origin ([@DMM031088C15]). Examples of CDD include epithelial dysplasia (tufting enteropathy), chloride or sodium diarrhea, Na-H-exchange deficiency, glucose-galactose malabsorption and SI deficiency ([@DMM031088C81]; [@DMM031088C98]).

It has been shown that MVID can be caused by mutations in either *MYO5B* (which occur in ∼90% of MVID patients) ([@DMM031088C79]; [@DMM031088C129]) or in *STX3* (two patients described so far) ([@DMM031088C138]). Both genes encode proteins that function in the intracellular trafficking machinery of epithelial cells in general ([Fig. 2](#DMM031088F2){ref-type="fig"}). However, the early and most severe clinical manifestations of MVID are mainly restricted to the intestinal epithelium. In addition, patients with mutations in *STXBP2* also have MVID in addition to their main clinical manifestation of familial hemophagocytic lymphohistiocytosis type 5 (FHL5) ([@DMM031088C118]; [@DMM031088C134]). Although many variations of MVID pathology have been described, the most common clinical and histological hallmarks of the disease are summarized in [Box 2](#DMM031088B2){ref-type="boxed-text"} and [Table 1](#DMM031088TB1){ref-type="table"}.

Intestinal biopsies of MVID patients exhibit villus atrophy, microvillus atrophy and the redistribution of CD10 and periodic acid Schiff (PAS)-stained material from the brush border to intracellular sites in the enterocytes ([@DMM031088C86]). In addition to CD10 and PAS staining, it has been proposed that the subapical localization of villin ([@DMM031088C113]) or RAB11 ([@DMM031088C122]) could be used as markers for MVID diagnosis. Analysis by electron microscopy (EM) is needed to reveal microvillus inclusions in the cytoplasm of enterocytes. However, the frequency of such inclusions can be very low and they are mainly restricted to the tips of the villi. For example, the enterocytes of some MVID patients exhibit features of the disease that are visible by light microscopy, such as subapical PAS and CD10 staining, but do not show microvillus inclusions under EM ([@DMM031088C75]). This variability might reflect the limitations of detection by EM or might be due to the heterogeneity of the disease, potentially caused by the variability of mutations in *MYO5B* ([@DMM031088C121]), *STX3* ([@DMM031088C138]) and *STXBP2* ([@DMM031088C118]; [@DMM031088C134]).

One might argue that much of the MVID phenotype results from the loss of microvilli and to the consequent loss of enterocyte surface area for efficient nutrient absorption. However, surface area reduction in MVID patients does not fully explain the MVID phenotype, and some patients even show normal-appearing microvilli ([@DMM031088C133]). The intestines of most MVID patients are in a secretory state, and excrete electrolytes and water even without enteral feeding ([@DMM031088C26]). The mislocalization of apical membrane proteins required for nutrient digestion, absorption and electrolyte transport might further explain their clinical symptoms ([@DMM031088C4]; [@DMM031088C30]; [@DMM031088C60]; [@DMM031088C73]; [@DMM031088C79]; [@DMM031088C133]).

A 16-fold expansion of the vesicular compartment, containing electron-dense vesicles and displaced mitochondria, has also been observed in intestinal biopsies from MVID patients ([@DMM031088C4]). Additional studies of MVID patient biopsies have revealed the aberrant localization of the apical proteins SI, sodium-hydrogen exchanger 2 (NHE2), NHE3, alkaline phosphatase (ALP), CFTR, dipeptidyl peptidase IV (DPP-IV), sodium-glucose linked transporter 1 (SGLT1) and phosphoinositide-dependent protein kinase 1 (PDK1) ([@DMM031088C4]; [@DMM031088C30]; [@DMM031088C60]; [@DMM031088C73]; [@DMM031088C79]; [@DMM031088C133]). Nevertheless, there is *in vitro* evidence to suggest that DPP-IV, SI and ALP are apically localized via a MYO5B/STX3-independent route, as these proteins are not mislocalized in Caco-2 cells that lack functioning MYO5B or STX3 proteins ([@DMM031088C133], [@DMM031088C132]). In addition, in the gut biopsies of some MVID patients, the basolateral membrane protein Na/K-ATPase was localized in the same pattern as it was in the gut biopsies of healthy controls ([@DMM031088C4]). The discrepancy between the results of these studies is most likely caused by the enormous variability of apical membrane morphology in MVID, which can range from membrane being devoid of microvilli and harboring numerous microvillus inclusion bodies to areas of membrane that appear to be morphologically healthy ([@DMM031088C85]; [@DMM031088C133]). Furthermore, it remains to be elucidated whether the mislocalization of membrane proteins is a consequence of microvilli loss or of mutant MYO5B inappropriately altering the localization of these proteins.

Mechanistic models for MVID {#s3b}
---------------------------

Taking the results from morphological and genetic studies together, three mechanistic models have been proposed to explain the main pathological hallmarks of MVID: lack of microvilli, protein mislocalization and the formation of microvillus inclusions ([Fig. 3](#DMM031088F3){ref-type="fig"}). The three models have been based on several studies using cell lines and MVID mouse models. We briefly explain each model below and propose a new combined model to explain the pathology of MVID. Fig. 3.**Three models to explain the pathological hallmarks of MVID.** The panels depict human enterocytes, showing endosomal trafficking routes (black arrows). The apical surface is uppermost. (A) In the trafficking model, defects (depicted by red crosses) in vesicle trafficking (caused by *MYO5B* mutations, MYO5B^MUT^) or delivery (caused by *STX3* mutations, STX3^MUT^) result in the subapical accumulation of vesicles and in the lack of appropriately polarized apical proteins. (B) In the recycling model, defects in the recycling and delivery of apical recycling endosomes (AREs) result in the subapical accumulation of apical proteins and in the formation of microvilli-containing macropinosomes. (C) In the local induction model, MVID results in colocalization of ezrin and ezrin kinases in the subapically accumulated AREs to create a signaling platform that results in local ectopic microvillus formation, which leads to the formation of microvillus inclusions (red arrows). In healthy cells, ezrin kinases are transported to the apical membrane where they activate ezrin by phosphorylation to induce microvillus formation.

### Trafficking model {#s3b1}

In this model, apical trafficking pathways are MYO5B- and STX3-dependent, and mutations lead to a failure of vesicle trafficking or to a failure of the fusion of vesicles with the plasma membrane ([@DMM031088C4]; [@DMM031088C97]; [@DMM031088C138]). This failure of vesicle trafficking causes vesicles that contain apical proteins to accumulate subapically ([Fig. 3](#DMM031088F3){ref-type="fig"}A).

### Recycling model {#s3b2}

In the recycling model, endocytosis and the subsequent recycling of apical proteins results in the internalization of apical proteins. In MVID, the re-expression of recycled apical proteins is compromised by the lack of vesicle trafficking or fusion by dysfunctional MYO5B or STX3. This model can also involve macropinocytosis (see Glossary, [Box 1](#DMM031088B1){ref-type="boxed-text"}), which can lead to the engulfment of large stretches of the plasma membrane, resulting in intracellular macropinosomes, potentially lined by microvilli ([@DMM031088C26]; [@DMM031088C54]; [@DMM031088C91]; [@DMM031088C97]) ([Fig. 3](#DMM031088F3){ref-type="fig"}B). It is currently not resolved whether microvillus inclusions in the enterocytes of MVID patients are in fact macropinosomes or if they are formed via a different mechanism.

### Local induction model {#s3b3}

As previously discussed, MYO5B is required for the localization of RAB11A-positive AREs, which contain various signaling molecules, such as PDK1, PKCi and MST4 ([@DMM031088C30]; [@DMM031088C60]; [@DMM031088C121]). Inside the AREs, these kinases colocalize with ezrin. This local induction model proposes that in MVID, RAB11A-positive AREs accumulate and function as a subapical signaling platform to induce ectopic intracellular microvillus formation ([@DMM031088C22]; [@DMM031088C30]; [@DMM031088C132]) ([Fig. 3](#DMM031088F3){ref-type="fig"}C).

### The combined model {#s3b4}

Here, we propose a novel hybrid model that combines all three models above. Vesicles, either derived from the Golgi complex or from apical/basolateral membranes by endocytosis, are transported from the perinuclear region to the cell periphery via microtubules and actin filaments. MYO5B is required to tether the vesicles to the actin filaments in the subapical area. At the plasma membrane, either docking or fusion of the vesicles via STX3 and STXBP2 is required to colocalize ezrin kinases in close proximity to ezrin. In MVID, where either MYO5B or STX3 function is disturbed, ARE cannot fuse with the apical membrane, which leads to the subapical accumulation of vesicles and ultimately gives rise to mislocalized microvilli and/or microvillus inclusions. Thus, microvillus inclusions are vesicles that have either sequestered the microvilli from the apical membrane by macropinocytosis or have formed ectopic microvilli owing to the colocalization of ezrin and ezrin kinases in the subapical compartment.

However, one issue that argues against the proposed combined model is that one would expect the microvilli to be internalized across the entire apical surface, which would result in the formation of numerous microvillus inclusions in each cell. By contrast, inclusions are mainly found at the villus tips and are rarely found in the intestinal crypts. Furthermore, inclusions are only observed in 10-20% of the enterocytes of *MYO5B* mutant MVID patients and of *Myo5b* knockout mice ([@DMM031088C22]; [@DMM031088C106]). It is possible that this phenotypic variation is caused by the initial, rapid degradation of inclusions in the lysosomes of immature IECs. When the degradation machinery is exhausted over time, inclusions start to accumulate and are therefore predominantly found in mature IECs at the tips of the villi. Because microvillus inclusions are not reliably present upon pathological examination of IECs from MVID patients ([@DMM031088C72]), additional genetic testing, such as of *MYO5B*, *STX3* and *STXBP2*, should be performed to confirm a MVID diagnosis. When these genes are not affected, a panel of genes involved in other CDDs ([@DMM031088C15]; [@DMM031088C81]) or genome-wide sequencing should be considered.

Investigating the polarity of intestinal epithelial cells {#s3c}
---------------------------------------------------------

Over the past few years, several studies have added to our understanding of MVID pathophysiology ([@DMM031088C60]; [@DMM031088C99]; [@DMM031088C124]; [@DMM031088C133], [@DMM031088C132]). In addition to studying primary tissue obtained by biopsy from MVID patients, genetically modified cell lines and animal models have also been developed and used to study MVID pathology, which are summarized below.

### Cell lines {#s3c1}

The *in vitro* systems used to study intestinal polarity and trafficking mostly derive from human colorectal adenocarcinomas, such as Caco-2 and LS174 cells. Caco-2 and Caco-2~BBE~ cells spontaneously polarize *in vitro*, when cultured in a tight monolayer for over 2 weeks ([@DMM031088C84]; [@DMM031088C82], [@DMM031088C83]). They form a mature brush border, express small intestine-specific enzymes, such as SI, and use trafficking routes specific for polarized cells, including direct biosynthetic trafficking and transcytosis ([@DMM031088C19]; [@DMM031088C36]; [@DMM031088C40]; [@DMM031088C65]; [@DMM031088C68]). Several research groups have used Caco-2 or Caco-2~BBE~ cells to study the effect of *MYO5B* knockdown (KD) and/or re-expression of various *MYO5B* mutants. Most of the *MYO5B* KD models develop the main characteristics of MVID, i.e. loss of microvilli, mislocalization of apical and basolateral proteins, and microvillus inclusions ([@DMM031088C60]; [@DMM031088C99]; [@DMM031088C124]; [@DMM031088C133], [@DMM031088C132]).

In one study, MYO5B-depleted Caco-2 cells formed very few microvilli; however, microvillus inclusions were not observed ([@DMM031088C54]). This could be caused by the incomplete KD of *MYO5B*, as MYO5B protein levels decreased by ∼50% in this study, whereas in other studies that achieved complete *MYO5B* KD or genome-edited Caco-2 cells, microvillus inclusions formed in the *MYO5B*-deficient cells ([@DMM031088C60]; [@DMM031088C124]; [@DMM031088C133]). In addition, the knock-in of the specific *MYO5B* mutation 1125G\>A, or overexpression of the *STX3* truncating mutations (AA1-125 and AA1-247), in Caco-2 cells all resulted in a MVID phenotype ([@DMM031088C132]; [@DMM031088C138]). However, as it has been shown that ±1% of Caco-2 cells exhibit spontaneous microvillus inclusions, the use of this cell line makes it difficult to reach conclusions about the direct effects of the introduced mutations.

The LS174-W4 cell line is also suitable to study intestinal epithelial polarization. The parental LS174T cells derive from a human colon adenocarcinoma ([@DMM031088C51]), and the daughter cell line, LS174-W4, was manipulated to stably express LKB1 and to inducibly express the pseudokinase, strad-α, both of which are required for ezrin phosphorylation ([@DMM031088C123]). Treatment of LS174-W4 cells with doxycyclin induces strad-α expression, which results in the polarization of individual cells, including the formation of a brush border and distinct apical and basolateral membrane domains ([@DMM031088C7]; [@DMM031088C123]). *MYO5B* KD in LS174-W4 cells resulted in the loss of microvilli and in mislocalized RAB11A-positive ARE-containing apical proteins ([@DMM031088C30]).

In summary, *MYO5B* KD in LS174-W4 and in Caco-2/Caco-2~BBE~ cells recapitulates the polarity defects that are observed in the enterocytes of MVID patients, albeit to varying degrees ([@DMM031088C30]; [@DMM031088C54]; [@DMM031088C59]; [@DMM031088C79]; [@DMM031088C124]; [@DMM031088C132]).

### Animal models {#s3c2}

Over recent years, various mouse models, as well as a zebrafish model ([@DMM031088C114]), have been used to study MVID. Here, we focus on the mouse models of this disease and summarize the findings in [Table 2](#DMM031088TB2){ref-type="table"}. In earlier mouse models of MVID, which were generated by *Rab8a*, *Rab11a* and *Cdc42* mutations, or combinations thereof, the animals failed to thrive due to unresolved causes ([@DMM031088C34]; [@DMM031088C71]; [@DMM031088C100]; [@DMM031088C103]; [@DMM031088C116]; [@DMM031088C139]). Microscopically, these MVID mouse models are characterized by abnormal microvilli, the mislocalization of apical proteins and by microvillus inclusions ([Table 2](#DMM031088TB2){ref-type="table"}). However, mutations in *RAB8A*, *RAB11A* and *CDC42* have, as yet, not been found in MVID patients. ([@DMM031088C122]; [@DMM031088C124]; [@DMM031088C133]). Most importantly, except for the *Rab8a*-deficient mice, none of these mouse models died from secretory diarrhea, which is the most devastating hallmark of human MVID ([Table 2](#DMM031088TB2){ref-type="table"}).

###### 

**Mouse models for human MVID**

![](dmm-11-031088-i2)

Recently, three independent papers described five different *Myo5b*-deficient mouse models, which were generated by using either an intestine-specific inducible *Myo5b* knockout ([@DMM031088C106]; [@DMM031088C136]) or a germline/constitutively targeted *Myo5b* knockout ([@DMM031088C16]; [@DMM031088C136]). All five *Myo5b*-deficient models recapitulated the human MVID phenotype: atrophy, complete loss or fusion of microvilli, a varying degree of cytoplasmic microvillus inclusions, the mislocalization of apical proteins, and the subapical accumulation of vesicles in enterocytes. Most importantly, all *Myo5b*-deficient mice died shortly after birth or after mutation induction due to severe secretory diarrhea. These findings demonstrated, for the first time, that lack of MYO5B causes all hallmarks of human MVID, including secretory diarrhea ([@DMM031088C16]; [@DMM031088C106]; [@DMM031088C136]). Interestingly, the induction of *Myo5b* deficiency in adult mice resulted in the presence of fewer microvillus inclusions in enterocytes compared to neonatally induced mice, in which many inclusions were observed. This indicates that the timing of mutation induction might have differential effects, although it is not yet understood how this is regulated ([@DMM031088C136]). It might reflect the findings in *MYO5B* KD Caco-2~BBE~ cells and human MVID enterocytes that maturation of MYO5B-deficient cells is retarded ([@DMM031088C61]).

In addition, the cytoplasmic mislocalization of apical proteins, such as of phospho-ezrin, CD10 and actin, and the subapical accumulation of electron-dense and translucent vesicles were observed in enterocytes of all five *Myo5b*-deficient mouse models. Interestingly, the enterocytic basolateral localization of E-cadherin and of Na/K-ATPase was unaffected in the germline and intestine-specific *Myo5b* knockout mouse models ([@DMM031088C16]; [@DMM031088C136]). However, both tamoxifen-inducible *Myo5b* knockout models displayed partly aberrant localization of E-cadherin and Na/K-ATPase in enterocytes ([@DMM031088C106]; [@DMM031088C136]). The presence of microvilli at the lateral membrane was described in only one of the five *Myo5b* knockout mouse models ([@DMM031088C16]). These phenotypic differences between the five *Myo5b*-deficient mouse models are currently not yet understood, and might simply reflect the variation in genetic background, age or timing of induction.

More studies are needed to determine whether the age of onset ([@DMM031088C136]), maturation stage of enterocytes ([@DMM031088C61]) and/or cephalocaudal location ([@DMM031088C136]) is correlated to the severity of the disease phenotype. For example, the inducible *Myo5b-*deficient mouse models can be used to study the sequence of events of the various disease-specific hallmarks, such as the origin of microvillus inclusions and the onset of secretory diarrhea, in an age-, time- and location-specific manner.

In summary, these *Myo5b*-deficient mouse models can be used to further investigate the molecular mechanisms underlying MVID and represent unique tools for the development and testing of novel therapeutic approaches.

### Organoids {#s3c3}

The generation of a three-dimensional primary intestinal culture system to create intestinal organoids has created new and exciting opportunities for studying IEC polarity. Organoids can be grown from single intestinal murine or human epithelial stem cells ([@DMM031088C105], [@DMM031088C104]). When grown in an extracellular matrix, such as matrigel, and supplemented with the right growth factors, intestinal stem cells grow to form a three-dimensional mini-intestine. This purely epithelial structure closely resembles the *in vivo* tissue ([@DMM031088C74]; [@DMM031088C105], [@DMM031088C104]), contains all of the main epithelial intestinal cell types and location-specific functional proteins and can be infinitely expanded without acquiring phenotypic or genetic abnormalities ([@DMM031088C9]; [@DMM031088C74]). Enterocytes in these organoids form a mature brush border and express apical and basolateral proteins on their respective membranes ([@DMM031088C105], [@DMM031088C104]). More recently, a new technique to culture organoids in a two-dimensional system has been established ([@DMM031088C76]; [@DMM031088C130]; [@DMM031088C134]). In this system, cells form a monolayer with distinct apical and basolateral membrane domains, allowing both domains to be easily accessed and manipulated.

Organoids derived from patients with polarity-associated diseases, such as MVID, cystic fibrosis (CF) or multiple intestinal atresia with a combined immunodeficiency (MIA-CID), faithfully recapitulate the disease phenotype ([@DMM031088C8]; [@DMM031088C27]; [@DMM031088C134]; [@DMM031088C138]). For example, intestinal organoids derived from MVID patients display microvillus atrophy, microvillus inclusions and subapical accumulations of vesicles. In addition, organoids derived from various MVID mouse models have been used to study the effects of the disease on stem cell proliferation and differentiation ([@DMM031088C34]; [@DMM031088C106]). As such, organoids derived from MVID patients or from mouse models provide a promising new tool for basic research on intestinal epithelial trafficking and the polarity machinery in healthy tissue, and for studying polarity-associated diseases in a patient-specific manner. Furthermore, the genetic manipulation of organoids by the use of viral transduction, bacterial artificial chromosome (BAC) transfection or the CRISPR/Cas9 gene editing system ([@DMM031088C58], [@DMM031088C57]; [@DMM031088C107],[@DMM031088C108]) provide tools with which to knockdown, overexpress or even repair genes to study their functions, in a polarized epithelial system that closely resembles the *in vivo* organ.

Conclusion {#s4}
==========

The plasma membrane of polarized intestinal epithelial cells contains distinct apical and basolateral domains with specialized functions. Much of our knowledge on how these distinct membrane domains are established and maintained has been gained from studying Caco-2 and LS174-W4 cells, which represent excellent *in vitro* models for polarity studies. Polarity-associated diseases, such as MVID, also serve as useful models to enhance our understanding of the intestinal trafficking and polarity machinery in health and disease. Over the past few years, several mouse models for MVID have been established. It was found that defects in several members of the apical trafficking pathway, such as Rab8a, Rab11a and Cdc42, resulted in some, but not all, hallmarks of human MVID, whereas deletion of *Myo5b* recapitulated MVID completely ([Tables 1](#DMM031088TB1){ref-type="table"} and [2](#DMM031088TB2){ref-type="table"}). The inducible *Myo5b*-defeicient models can now be used to study the sequence of events on a cellular level in a physiological context, which is not possible with *in vitro* models of genetically manipulated cell lines.

However, the mutations seen in MVID patients are very heterogeneous, and disease phenotypes can vary between individual patients, with some patients even being reported to have episodes where they can tolerate (partial) enteral feeding ([@DMM031088C85]; [@DMM031088C98]). By contrast, all mouse models resulted in a complete loss of function of the MYO5B protein. This underlines the importance to not only rely on *in vitro* or *in vivo* models to elucidate the pathophysiology of MVID, but to combine those models with patient data. Indeed, new genetic mutations causing MVID have been identified recently, and an online MVID patient registry has been established ([@DMM031088C129]). Furthermore, we foresee that the use of primary *in vitro* models, such as intestinal organoids, will play an important role in intestinal polarity studies, because they contain the patient-specific mutation and can be used to study the epithelial pathophysiological defects. The main advantage of using organoids is that they can be easily established from mouse models as well as from individual patients ([@DMM031088C106]; [@DMM031088C134]; [@DMM031088C138]), and can be infinitely expanded in culture. Whereas the analysis of patient biopsies always represents a static picture of the moment when the biopsy was taken, organoids derived from patients allow for a dynamic analysis of the disease phenotype by functional assays or live cell imaging ([@DMM031088C27]). Furthermore, the use of organoids enables personalized interventions, such as nutrient challenges, personalized drug screening and drug development ([@DMM031088C28]).

Currently, MVID diagnosis is dependent on classical histology and (electron) microscopy, while the variability of described features could lead to misinterpretation or incorrect diagnosis of MVID. In addition, there are patients known to present with an MVID phenotype, but do not harbor mutations in *MYO5B*, *STX3* or *STXBP2*, suggesting the involvement of yet unknown genes in causing MVID (S.M., personal communication). Therefore, we suggest the inclusion of standard genetic testing as standard workflow for MVID patients, expansion of the MVID patient registry, and creation and biobanking of patient-specific stem cell-based organoids from MVID patients to allow genotype-to-phenotype comparisons ([Box 3](#DMM031088B3){ref-type="boxed-text"}). The additional genetic and clinical information in the patient registry will allow a better understanding of the variations in the MVID phenotype, and will provide clinicians with a better overview of the clinical presentations that are related to MVID.

###### Box 3. Combined approaches for MVID research, diagnosis and treatment

Currently, a MVID diagnosis is dependent on classical histology and (electron) microscopy, while the variability of described features could lead to misinterpretation or incorrect diagnosis of MVID. Therefore, we suggest the following combined approach as a standard workflow for MVID patients:

• Standardized genetic testing and extensive automated microscopy to enhance the differential diagnosis of MVID in the clinic.

• The expansion and maintenance of MVID patient registries that integrate basic, genetic and clinical data to allow genotype-to-phenotype comparisons.

• Creating and biobanking patient-derived stem cell-based organoids from MVID patients for disease modeling, drug screening and drug development.
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